Interventions to Reduce Antimicrobial Resistance in Low and Middle-Income Countries

Dear Colleagues,

Many interventions to reduce antimicrobial resistance (AMR) have been designed and implemented in high-income countries. However, the risk of antimicrobial resistance (AMR) emerging is substantial in low- and middle-income countries (LMICs), where the health systems and regulations are often weak, awareness is limited, and competing socioeconomic challenges are constantly emerging. The World Health Organization (WHO)’s Global Action Plan on AMR called for actions to improve the knowledge and awareness of AMR, and the rational use of antibiotics, and to develop national plans to build up antimicrobial stewardship programmes in both the human and animal health sectors. The current pandemic caused by the novel coronavirus SARS-CoV-2 reaffirms the importance of a one-health approach.

This Special Issue calls for studies regarding interventions to reduce AMR in LMICs. The theme includes interventions at the health-system and policy levels; stewardship programmes in hospitals, primary care facilities and pharmacies; and interventions at the community level, as well as interventions using the one-health concept that cover both human and animal health. Studies employing implementation science frameworks will be particularly interesting because they not only demonstrate what works (or not) but also show how the interventions are implemented and under which contexts. We welcome original studies, reviews, and comparative analyses conducted in LMICs or relevant to LMICs.

Prof. Dr. Xiaolin Wei
Dr. Rebecca King
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.